申请人:River Stone Biotech APS
公开号:US20210230655A1
公开(公告)日:2021-07-29
The invention relates to recombinant host cells that expresses one or more genes encoding a cytochrome P450 enzyme capable of N-demethylating and/O-demethylating reticuline and/or derivatives thereof, and also methods of producing a N-demethylated and/or O-demethylated reticuline and/or derivatives thereof, comprising cultivating the recombinant host of the invention in a culture medium under conditions in which the one or more genes encoding the cytochrome P450 enzymes is/are expressed. The reticuline and derivatives thereof are useful for providing access to naturally unavailable and chemically difficult-to-produce starting materials for opioids.
该发明涉及重组宿主细胞,该细胞表达一个或多个编码细胞色素P450酶的基因,该酶能够对莱角碱和/或其衍生物进行N-去甲基化和/或O-去甲基化,并且还涉及生产N-去甲基化和/或O-去甲基化的莱角碱和/或其衍生物的方法,包括在培养基中培养该发明的重组宿主细胞,在该条件下,编码细胞色素P450酶的一个或多个基因被表达。莱角碱及其衍生物可用于提供自然无法获得和化学上难以生产的阿片类药物的起始物质。